DR. MEI ZHENG, MD
Medical Practice at 15 St, Augusta, GA
License number
Georgia 003628
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
License number
Georgia 74460
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
1120 15Th St, Augusta, GA 30912
Phone
(706) 721-5118
(706) 774-5430
(610) 271-4245 (Fax)
(706) 774-5430
(610) 271-4245 (Fax)
Personal information
See more information about MEI ZHENG at radaris.comName
Address
Phone
3707 Raintree Dr, Hephzibah, GA 30815
5816 Carriage Hills Dr, Augusta, GA 30907
1439 Lady Slipper Ct NW, Kennesaw, GA 30152
Augusta, GA
Professional information
Dr. Mei Zheng, Augusta GA - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
1120 15Th St, Augusta 30912
(706) 721-5118 (Phone), (706) 721-7781 (Fax)
(706) 721-5118 (Phone), (706) 721-7781 (Fax)
Languages:
English
Hospitals:
1120 15Th St, Augusta 30912
Georgia Regents Medical Center
1120 15Th Street Ext, Augusta 30912
Georgia Regents Medical Center
1120 15Th Street Ext, Augusta 30912
Use Of Cpg Oligodeoxynucleotides To Induce Angiogenesis
US Patent:
2005002, Feb 3, 2005
Filed:
Dec 19, 2002
Appl. No.:
10/499597
Inventors:
Dennis Klinman - Potomac MD, US
Mei Zheng - Augusta GA, US
Barry Rouse - Knoxville TN, US
Mei Zheng - Augusta GA, US
Barry Rouse - Knoxville TN, US
International Classification:
A61K048/00, C07H021/02, C12N005/08, C12N015/86
US Classification:
435069100, 435320100, 435372000, 514044000, 435456000, 536023100
Abstract:
This disclosure provides a method of inducing production of vascular endothelial growth factor by a cell. The method includes contacting the cell with a CpG oligonucleotide, thereby inducing the production of vascular endothelial growth factor by the cell. The disclosure further provides a method inducing neovascularization in a tissue. This method includes comprising introducing a CpG oligodeoxynucleotide into an area of the tissue wherein the formation of new blood vessels is desired, thereby inducing neovascularization in the area of the tissue.
Use Of Cpg Oligodeoxynucleotides To Induce Angiogenesis
US Patent:
7935351, May 3, 2011
Filed:
Aug 15, 2007
Appl. No.:
11/839217
Inventors:
Dennis M. Klinman - Potomac MD, US
Mei Zheng - Augusta GA, US
Barry T. Rouse - Knoxville TN, US
Mei Zheng - Augusta GA, US
Barry T. Rouse - Knoxville TN, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
University of Tennessee Research Foundation - Knoxville TN
University of Tennessee Research Foundation - Knoxville TN
International Classification:
A61K 39/00, A61K 39/38, A61K 45/00, A61K 47/00, A01N 43/04
US Classification:
4241981, 4241841, 4242781, 514 44 R
Abstract:
This disclosure provides a method of inducing production of vascular endothelial growth factor by a cell. The method includes contacting the cell with a CpG oligonucleotide, thereby inducing the production of vascular endothelial growth factor by the cell. The disclosure further provides a method inducing neovascularization in a tissue. This method includes comprising introducing a CpG oligodeoxynucleotide into an area of the tissue wherein the formation of new blood vessels is desired, thereby inducing neovascularization in the area of the tissue.